Nrf2/HO-1信号通路在胃癌发生和治疗中的作用
Role of Nrf2/HO-1 Signaling Pathway in the Genesis and Treatment of Gastric Cancer
DOI: 10.12677/ACM.2023.134783, PDF,   
作者: 周 璇, 王 霞：甘肃中医药大学第一临床医学院，甘肃 兰州；甘肃省人民医院肿瘤内科，甘肃 兰州；蒋 兵：甘肃中医药大学中西医结合学院，甘肃 兰州；李红玲*：甘肃省人民医院肿瘤内科，甘肃 兰州
关键词: 胃癌；Nrf2/HO-1信号通路；机制；诊断；治疗；Gastric Cancer； Nrf2/HO-1 Signaling Pathway； Mechanism； Diagnosis； Treatment
摘要: 胃癌(GC)是我国最常见的恶性肿瘤之一，其明确的发病机制仍是一个亟待解决的问题。Nrf2/HO-1信号通路是细胞氧化应激的重要信号通路，研究发现Nrf2/HO-1信号通路的异常激活或累积能影响胃癌细胞的生长、血管形成及耐药性。本文将详细论述Nrf2/HO-1信号通路与胃癌之间的相互作用及其耐药机制，为提高胃癌的诊断、预防和治疗提供有效的技术手段。
Abstract: Gastric cancer (GC) is one of the most common malignant tumors in our country, its clear pathogen-esis is still a problem to be solved. Nrf2/HO-1 signaling pathway is an important signaling pathway of cellular oxidative stress. Studies have shown that abnormal activation or accumulation of Nrf2/HO-1 signaling pathway can affect the growth, angiogenesis and drug resistance of gastric cancer cells. In this paper, the interaction between Nrf2/HO-1 signaling pathway and gastric cancer and the mechanism of drug resistance will be discussed in detail, so as to provide effective technical means for improving the diagnosis, prevention and treatment of gastric cancer.
文章引用：周璇, 蒋兵, 王霞, 李红玲. Nrf2/HO-1信号通路在胃癌发生和治疗中的作用[J]. 临床医学进展, 2023, 13(4): 5536-5542. https://doi.org/10.12677/ACM.2023.134783

参考文献

[1] Wang, X., Ye, T., Xue, B., et al. (2021) Mitochondrial GRIM-19 Deficiency Facilitates Gastric Cancer Metastasis through Oncogenic ROS-NRF2-HO-1 Axis via a NRF2-HO-1 Loop. Gastric Cancer, 24, 117-132. [Google Scholar] [CrossRef] [PubMed]
[2] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[3] Ilic, M. and Ilic, I. (2022) Epidemiology of Stomach Cancer. World Jour-nal of Gastroenterology, 28, 1187-1203. [Google Scholar] [CrossRef] [PubMed]
[4] 曹毛毛, 陈万青. GLOBOCAN2020全球癌症统计数据解读[J]. 中国医学前沿杂志(电子版), 2021, 13(3): 63-69.
[5] 舍雅莉, 赵晓文, 李俊杰, 等. 敦煌平胃丸联合顺铂对SCG-7901胃癌荷瘤小鼠的抑瘤作用及肾毒性研究[J]. 中药药理与临床, 2021, 37(2): 13-18. [Google Scholar] [CrossRef] 
[6] Machlowska, J., Baj, J., Sitarz, M., et al. (2020) Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences, 21, 4012. [Google Scholar] [CrossRef] [PubMed]
[7] 罗劲松, 何淼, 杨桄权. 胃癌的临床诊断、形成机理以及临床治疗[J]. 基因组学与应用生物学, 2021, 40(2): 936-940. [Google Scholar] [CrossRef] 
[8] Wang, K., Chen, Q., Shao, Y., et al. (2021) Anticancer Activities of TCM and Their Active Components against Tumor Metastasis. Biomedicine & Pharmacotherapy, 133, Article ID: 111044. [Google Scholar] [CrossRef] [PubMed]
[9] Petryszyn, P., Chapelle, N. and Matysiak-Budnik, T. (2020) Gastric Cancer: Where Are We Heading? Digestive Diseases, 38, 280-285. [Google Scholar] [CrossRef] [PubMed]
[10] Smyth, E.C., Nilsson, M., Grabsch, H.I., et al. (2020) Gastric Cancer. The Lancet, 396, 635-648. [Google Scholar] [CrossRef] 
[11] Li, B., Nasser, M.I., Masood, M., et al. (2020) Efficiency of Traditional Chinese Medicine Targeting the Nrf2/HO-1 Signaling Pathway. Biomedicine & Pharmacotherapy, 126, Arti-cle ID: 110074. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, C., Yuan, Y., Wu, J., et al. (2019) Plin5 Deficiency Ex-acerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure by Enhancing Myocardial Fatty Acid Oxi-dation and Oxidative Stress. Free Radical Biology and Medicine, 141, 372-382. [Google Scholar] [CrossRef] [PubMed]
[13] Katsuoka, F., Otsuki, A., Takahashi, M., et al. (2019) Direct and Specific Functional Evaluation of the Nrf2 and MafG Heterodimer by Introducing a Tethered Dimer into Small Maf-Deficient Cells. Molecular and Cellular Biology, 39, e00273-19. [Google Scholar] [CrossRef] 
[14] Silva-Palacios, A., Ostolga-Chavarría, M., Zazueta, C., et al. (2018) Nrf2: Molecular and Epigenetic Regulation during Aging. Ageing Research Reviews, 47, 31-40. [Google Scholar] [CrossRef] [PubMed]
[15] Hybertson, B.M., Gao, B., Bose, S.K., et al. (2011) Oxidative Stress in Health and Disease: The Therapeutic Potential of Nrf2 Activation. Molecular Aspects of Medicine, 32, 234-246. [Google Scholar] [CrossRef] [PubMed]
[16] Na, H.K. and Surh, Y.J. (2014) Oncogenic Potential of Nrf2 and Its Principal Target Protein Heme Oxygenase-1. Free Radical Biology and Medicine, 67, 353-365. [Google Scholar] [CrossRef] [PubMed]
[17] Chiang, S.K., Chen, S.E. and Chang, L.C. (2018) A Dual Role of Heme Oxygenase-1 in Cancer Cells. International Journal of Molecular Sciences, 20, 39. [Google Scholar] [CrossRef] [PubMed]
[18] Nitti, M., Piras, S., Marinari, U., et al. (2017) HO-1 Induction in Can-cer Progression: A Matter of Cell Adaptation. Antioxidants, 6, 29. [Google Scholar] [CrossRef] [PubMed]
[19] Menegon, S., Columbano, A. and Giordano, S. (2016) The Dual Roles of NRF2 in Cancer. Trends in Molecular Medicine, 22, 578-593. [Google Scholar] [CrossRef] [PubMed]
[20] Farkhondeh, T., Folgado, S.L., Pourbagher-Shahri, A.M., et al. (2020) The Therapeutic Effect of Resveratrol: Focusing on the Nrf2 Signaling Pathway. Biomedicine & Pharmacothera-py, 127, Article ID: 110234. [Google Scholar] [CrossRef] [PubMed]
[21] Sporn, M.B. and Liby, K.T. (2012) NRF2 and Cancer: The Good, the Bad and the Importance of Context. Nature Reviews Cancer, 12, 564-571. [Google Scholar] [CrossRef] [PubMed]
[22] Deshmukh, P., Unni, S., Krishnappa, G., et al. (2017) The Keap1-Nrf2 Path-way: Promising Therapeutic Target to Counteract ROS-Mediated Damage in Cancers and Neurodegenerative Diseases. Biophysical Reviews, 9, 41-56. [Google Scholar] [CrossRef] [PubMed]
[23] Deng, Y., Wu, Y., Zhao, P., et al. (2019) The Nrf2/HO-1 Axis Can Be a Prognostic Factor in Clear Cell Renal Cell Carcinoma. Cancer Management and Research, 11, 1221-1230. [Google Scholar] [CrossRef] 
[24] Yang, Y., Wang, X., Zhang, J., et al. (2022) Abnormal Phenotype of Nrf2 Is Associated with Poor Prognosis through Hypoxic/VEGF-A-Rap1b/VEGFR2 Pathway in Gastric Cancer. Aging (Albany NY), 14, 3293-3312. [Google Scholar] [CrossRef] [PubMed]
[25] 陈骢, 郝健淇, 彭皓宁, 等. BCL-2家族凋亡调控作用及其介导的抗肿瘤药物治疗后耐药的研究进展[J]. 中国胸心血管外科临床杂志, 2023, 30(1): 140-148.
[26] Boise, H., Gonzblez-Garcia, M., Postema, E., et al. (1993) bcl-x, a bcl-2-Related Gene that Functions as a Dominant Regulator of Apoptotic Cell Death. Cell, 74, 597-608. [Google Scholar] [CrossRef] 
[27] Jakovic, L.R., Mihaljevic, B.S., Jovanovic, M.D.P., et al. (2012) Prognostic Significance of Bcl-2, Tumor-Associated Macrophages, and Total Neoplastic and Inflammatory Lymph Node Involvement in Advanced Stage Classical Hodgkin’s Lymphoma. Oncology Research and Treatment, 35, 733-739. [Google Scholar] [CrossRef] [PubMed]
[28] Zimta, A.A., Cenariu, D., Irimie, A., et al. (2019) The Role of Nrf2 Activity in Cancer Development and Progression. Cancers, 11, 1755. [Google Scholar] [CrossRef] [PubMed]
[29] Ashrafizadeh, M., Fekri, H.S., Ahmadi, Z., et al. (2020) Therapeutic and Biological Activities of Berberine: The Involvement of Nrf2 Signaling Pathway. Journal of Cellular Biochemistry, 121, 1575-1585. [Google Scholar] [CrossRef] [PubMed]
[30] 谢晶日, 张瑜, 张冰. 探讨Keap1/Nrf-2信号通路在胃癌发展和治疗中的作用[C]//中国中西医结合学会基础理论专业委员会. 第十四届中国中西医结合基础理论学术年会会议资料. [出版者不详], 2018: 7.
[31] Shibuya, M. (2013) Vascular Endothelial Growth Factor and Its Receptor System: Physi-ological Functions in Angiogenesis and Pathological Roles in Various Diseases. The Journal of Biochemistry, 153, 13-19. [Google Scholar] [CrossRef] [PubMed]
[32] Goel, H.L. and Mercurio, A.M. (2013) VEGF Targets the Tumour Cell. Nature Reviews Cancer, 13, 871-882. [Google Scholar] [CrossRef] [PubMed]
[33] Melincovici, C.S., Bo, A.B., Mihu, C., et al. (2018) Vascular Endothelial Growth Factor (VEGF)—Key Factor in Normal and Pathological Angiogenesis. Romanian Journal of Morphology and Embryology, 59, 455-467.
[34] Cuzziol, C.I., Castanhole-Nunes, M.M.U., Pavarino, É.C., et al. (2020) MicroRNAs as Regulators of VEGFA and NFE2L2 in Cancer. Gene, 759, Article ID: 144994. [Google Scholar] [CrossRef] [PubMed]
[35] Li, R., Jia, Z. and Zhu, H. (2019) Regulation of Nrf2 Signaling. The Reactive Oxygen Species (Apex), 8, 312-322. [Google Scholar] [CrossRef] 
[36] Ma, Q. (2013) Role of Nrf2 in Oxidative Stress and Toxicity. Annual Review of Pharmacology and Toxicology, 53, 401-426. [Google Scholar] [CrossRef] [PubMed]
[37] Jaramillo, M.C. and Zhang, D.D. (2013) The Emerging Role of the Nrf2-Keap1 Signaling Pathway in Cancer. Genes & Development, 27, 2179-2191. [Google Scholar] [CrossRef] [PubMed]
[38] Kawasaki, Y. (2015) Clinicopathological Significance of Nuclear Factor (Erythroid-2)-Related Factor 2 (Nrf2) Expression in Gastric Cancer. BMC Cancer, 15, Article No. 5. [Google Scholar] [CrossRef] [PubMed]
[39] Januchowski, R., Wojtowicz, K. andrzejewska, M., et al. (2014) Expression of MDR1 and MDR3 Gene Products in Paclitaxel-, Doxorubicin- and Vincristine-Resistant Cell Lines. Bio-medicine & Pharmacotherapy, 68, 111-117. [Google Scholar] [CrossRef] [PubMed]
[40] Jeddi, F., Soozangar, N., Sadeghi, M.R., et al. (2017) Contra-dictory Roles of Nrf2/Keap1 Signaling Pathway in Cancer Prevention/Promotion and Chemoresistance. DNA Repair, 54, 13-21. [Google Scholar] [CrossRef] [PubMed]
[41] 康意, 张静, 王晓玲, 等. Nrf2-ARE通路与肿瘤耐药的研究进展[J]. 医学综述, 2019, 25(23): 4662-4667.
[42] Jeddi, F., Soozangar, N., Sadeghi, M.R., et al. (2018) Nrf2 Overexpression Is Associated with P-Glycoprotein Upregulation in Gastric Cancer. Biomedicine & Pharmacotherapy, 97, 286-292. [Google Scholar] [CrossRef] [PubMed]
[43] Wang, X., Campos, C.R., Peart, J.C., et al. (2014) Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers. Journal of Neuroscience, 34, 8585-8593. [Google Scholar] [CrossRef] 

为你推荐